GE HealthCare Expands DeepHealth AI Breast Suite Partnership Internationally
GE HealthCare expanded its partnership with DeepHealth to integrate AI-powered Breast Suite with Senographe Pristina systems internationally, adding a second-reader workflow and cloud-based viewer for density assessment and lesion detection. The agreement extends ProFound Pro and Safeguard Review distribution via Pristina Via, boosting early cancer detection and streamlining screening operations.
1. International Expansion
GE HealthCare and DeepHealth have moved into new markets by rolling out the integrated Breast Suite solution globally. This phase adds support for multiple regions using the Senographe Pristina mammography system combined with DeepHealth’s AI screening workflow.
2. AI Breast Suite Features
The modular, cloud-based Breast Suite includes a second-reader workflow, density assessment, AI-based lesion detection, prioritized worklists and timely alerts. The cloud-first viewer ensures seamless integration with existing imaging operations and scalable screening capacity.
3. Deployment of ProFound Pro and Safeguard Review
GE HealthCare will distribute ProFound Pro for AI-driven lesion detection and density assessment alongside Safeguard Review, an optional workflow for complex case analysis. Pristina Via serves as the delivery platform, enhancing diagnostic confidence and workflow efficiency.
4. Additional Imaging Collaborations
Earlier this month, GE HealthCare integrated its bkActiv intraoperative ultrasound system with Medtronic’s Stealth AXiS surgical navigation solution to support cranial procedures. These partnerships reinforce GE HealthCare’s strategy to expand its imaging capabilities across clinical settings.